Literature DB >> 27012913

Quillaja brasiliensis saponins induce robust humoral and cellular responses in a bovine viral diarrhea virus vaccine in mice.

Samuel Paulo Cibulski1, Fernando Silveira2, Gustavo Mourglia-Ettlin3, Thais Fumaco Teixeira1, Helton Fernandes dos Santos1, Anna Carolina Yendo4, Fernanda de Costa4, Arthur Germano Fett-Neto4, Grace Gosmann5, Paulo Michel Roehe1.   

Abstract

A saponin fraction extracted from Quillaja brasiliensis leaves (QB-90) and a semi-purified aqueous extract (AE) were evaluated as adjuvants in a bovine viral diarrhea virus (BVDV) vaccine in mice. Animals were immunized on days 0 and 14 with antigen plus either QB-90 or AE or an oil-adjuvanted vaccine. Two-weeks after boosting, antibodies were measured by ELISA; cellular immunity was evaluated by DTH, lymphoproliferation, cytokine release and single cell IFN-γ production. Serum anti-BVDV IgG, IgG1 and IgG2b were significantly increased in QB-90- and AE-adjuvanted vaccines. A robust DTH response, increased splenocyte proliferation, Th1-type cytokines and enhanced production of IFN-γ by CD4(+) and CD8(+) T lymphocytes were detected in mice that received QB-90-adjuvanted vaccine. The AE-adjuvanted preparation stimulated humoral responses but not cellular immune responses. These findings reveal that QB-90 is capable of stimulating both cellular and humoral immune responses when used as adjuvant.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; BVDV; Cellular immunity; Immune response; QB-90; Quillaja brasiliensis; Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27012913     DOI: 10.1016/j.cimid.2016.01.004

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  4 in total

1.  Preparation and efficacy of freeze-dried inactivated vaccine against bovine viral diarrhea virus genotypes 1 and 2, bovine herpes virus type 1.1, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus.

Authors:  Maha Raafat Abd El Fadeel; Ashraf Taha El-Dakhly; Ahmad Mohammad Allam; Tarek Korany Farag; Alaa Abdel-Moneim El-Kholy
Journal:  Clin Exp Vaccine Res       Date:  2020-07-31

2.  Zika Virus Envelope Domain III Recombinant Protein Delivered With Saponin-Based Nanoadjuvant From Quillaja brasiliensis Enhances Anti-Zika Immune Responses, Including Neutralizing Antibodies and Splenocyte Proliferation.

Authors:  Samuel Cibulski; Ana Paula Muterle Varela; Thais Fumaco Teixeira; Martín Pablo Cancela; Patrícia Sesterheim; Diogo Onofre Souza; Paulo Michel Roehe; Fernando Silveira
Journal:  Front Immunol       Date:  2021-03-04       Impact factor: 7.561

3.  ISCOM-Matrices Nanoformulation Using the Raw Aqueous Extract of Quillaja lancifolia (Q. brasiliensis).

Authors:  Samuel Cibulski; Fernando Silveira; Thalisson Amorim de Souza; Joanda Paola Raimundo; Yuri Mangueira Nascimento; Lucas Silva Abreu; Norma Suarez; Iris Miraballes; Paulo Michael Roehe; Demetrius Antonio Machado de Araújo; Josean Fechine Tavares; Marcelo Sobral da Silva
Journal:  Bionanoscience       Date:  2022-08-06

4.  Quillaja brasiliensis saponin-based nanoparticulate adjuvants are capable of triggering early immune responses.

Authors:  Samuel Paulo Cibulski; Mariana Rivera-Patron; Gustavo Mourglia-Ettlin; Cecilia Casaravilla; Anna Carolina Alves Yendo; Arthur Germano Fett-Neto; José Alejandro Chabalgoity; María Moreno; Paulo Michel Roehe; Fernando Silveira
Journal:  Sci Rep       Date:  2018-09-11       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.